Figure 1
Mechanism of action and cardiotoxicity of drugs belonging to VEGF-i, BTK-i, and proteasome inhibitors. BTK-i, Bruton’s tyrosine kinase inhibitor; ER, endoplasmic reticulum; VEGFi, vascular endothelial growth factor inhibitor; PI, protheosome inhibitor. Created with Biorender.com

Mechanism of action and cardiotoxicity of drugs belonging to VEGF-i, BTK-i, and proteasome inhibitors. BTK-i, Bruton’s tyrosine kinase inhibitor; ER, endoplasmic reticulum; VEGFi, vascular endothelial growth factor inhibitor; PI, protheosome inhibitor. Created with Biorender.com

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close